日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial

Quemliclustat联合化疗(加或不加zimberelimab)治疗转移性胰腺腺癌:一项随机1期试验

Wainberg, Zev A; Manji, Gulam A; Bahary, Nathan; Ulahannan, Susanna V; Pant, Shubham; Spigel, David R; Uboha, Nataliya V; Oberstein, Paul E; Saeed, Anwaar; Beagle, Brandon; Kim, Ji Yun; Wang, Ning; Weeder, Ben; Shitole, Shravani; Mrouj, Karim; Scott, Jennifer R; Ensign, Lisa G; DiRenzo, Daniel M; Walters, Matthew J; Wu, Wilson; Kaplan, Angelo; Cho, Soonweng; Kabbarah, Omar; O'Reilly, Eileen M

Reciprocal regulation of p21 and Chk1 controls the cyclin D1-RB pathway to mediate senescence onset after G2 arrest

p21 和 Chk1 的相互调节控制细胞周期蛋白 D1-RB 通路介导 G2 停滞后的衰老开始

Gérald Lossaint, Anđela Horvat, Véronique Gire, Katarina Bačević, Karim Mrouj, Fabienne Charrier-Savournin, Virginie Georget, Daniel Fisher, Vjekoslav Dulić

Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis

Ki-67调控整体基因表达并促进癌变过程的各个阶段。

Mrouj, Karim; Andrés-Sánchez, Nuria; Dubra, Geronimo; Singh, Priyanka; Sobecki, Michal; Chahar, Dhanvantri; Al Ghoul, Emile; Aznar, Ana Bella; Prieto, Susana; Pirot, Nelly; Bernex, Florence; Bordignon, Benoit; Hassen-Khodja, Cedric; Villalba, Martin; Krasinska, Liliana; Fisher, Daniel

Cell-Cycle Regulation Accounts for Variability in Ki-67 Expression Levels

细胞周期调控导致 Ki-67 表达水平的变化

Michal Sobecki, Karim Mrouj, Jacques Colinge, François Gerbe, Philippe Jay, Liliana Krasinska, Vjekoslav Dulic, Daniel Fisher

The cell proliferation antigen Ki-67 organises heterochromatin

细胞增殖抗原 Ki-67 组织异染色质

Michal Sobecki, Karim Mrouj, Alain Camasses, Nikolaos Parisis, Emilien Nicolas, David Llères, François Gerbe, Susana Prieto, Liliana Krasinska, Alexandre David, Manuel Eguren, Marie-Christine Birling, Serge Urbach, Sonia Hem, Jérôme Déjardin, Marcos Malumbres, Philippe Jay, Vjekoslav Dulic, Denis Lj